Logo image of ALBPK.PA

BROADPEAK (ALBPK.PA) Stock Fundamental Analysis

Europe - EPA:ALBPK - FR001400AJZ7 - Common Stock

2.52 EUR
+0.03 (+1.2%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALBPK gets a fundamental rating of 2 out of 10. We evaluated ALBPK against 28 industry peers in the Communications Equipment industry. ALBPK may be in some trouble as it scores bad on both profitability and health. ALBPK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALBPK had negative earnings in the past year.
ALBPK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALBPK reported negative net income in multiple years.
In multiple years ALBPK reported negative operating cash flow during the last 5 years.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ALBPK's Return On Assets of -7.91% is on the low side compared to the rest of the industry. ALBPK is outperformed by 64.29% of its industry peers.
Looking at the Return On Equity, with a value of -19.96%, ALBPK is doing worse than 67.86% of the companies in the same industry.
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

Looking at the Gross Margin, with a value of 100.47%, ALBPK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ALBPK's Gross Margin has improved in the last couple of years.
ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

3

2. Health

2.1 Basic Checks

ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALBPK remains at a similar level compared to 1 year ago.
ALBPK has a better debt/assets ratio than last year.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALBPK has an Altman-Z score of 0.99. This is a bad value and indicates that ALBPK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.99, ALBPK perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
ALBPK has a debt to FCF ratio of 16.11. This is a negative value and a sign of low solvency as ALBPK would need 16.11 years to pay back of all of its debts.
The Debt to FCF ratio of ALBPK (16.11) is worse than 71.43% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that ALBPK is not too dependend on debt financing.
ALBPK has a Debt to Equity ratio of 0.44. This is comparable to the rest of the industry: ALBPK outperforms 46.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Altman-Z 0.99
ROIC/WACCN/A
WACC6.9%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.29 indicates that ALBPK should not have too much problems paying its short term obligations.
ALBPK has a worse Current ratio (1.29) than 71.43% of its industry peers.
ALBPK has a Quick Ratio of 1.29. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
ALBPK has a Quick ratio (1.29) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

ALBPK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.09%.
Looking at the last year, ALBPK shows a small growth in Revenue. The Revenue has grown by 0.87% in the last year.
ALBPK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.93% yearly.
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%

3.2 Future

Based on estimates for the next years, ALBPK will show a very strong growth in Earnings Per Share. The EPS will grow by 43.18% on average per year.
Based on estimates for the next years, ALBPK will show a quite strong growth in Revenue. The Revenue will grow by 8.91% on average per year.
EPS Next Y75.81%
EPS Next 2Y45.91%
EPS Next 3Y43.18%
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y8.99%
Revenue Next 3Y8.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

ALBPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALBPK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALBPK indicates a slightly more expensive valuation: ALBPK is more expensive than 71.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 46.4
EV/EBITDA N/A
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALBPK's earnings are expected to grow with 43.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.91%
EPS Next 3Y43.18%

0

5. Dividend

5.1 Amount

No dividends for ALBPK!.
Industry RankSector Rank
Dividend Yield N/A

BROADPEAK

EPA:ALBPK (9/26/2025, 7:00:00 PM)

2.52

+0.03 (+1.2%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.88%
Inst Owner ChangeN/A
Ins Owners49.73%
Ins Owner ChangeN/A
Market Cap31.60M
Analysts86
Price Target2.81 (11.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-275%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.8
P/FCF 46.4
P/OCF 3.1
P/B 1.57
P/tB 11.81
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.05
FCFY2.16%
OCF(TTM)0.81
OCFY32.28%
SpS3.14
BVpS1.61
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100.48%
FCFM 1.73%
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Debt/EBITDA N/A
Cap/Depr 175.48%
Cap/Sales 24.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 0.99
F-Score6
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)283.73%
Cap/Depr(5y)362.99%
Cap/Sales(3y)24.24%
Cap/Sales(5y)18.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y75.81%
EPS Next 2Y45.91%
EPS Next 3Y43.18%
EPS Next 5YN/A
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%
Revenue Next Year11.68%
Revenue Next 2Y8.99%
Revenue Next 3Y8.91%
Revenue Next 5YN/A
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year171.06%
EBIT Next 3Y53.71%
EBIT Next 5YN/A
FCF growth 1Y104.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y371.81%
OCF growth 3Y167.99%
OCF growth 5YN/A